1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Global Mass Spectrometry Market

Global Mass Spectrometry Market

  • July 2013
  • -
  • Frost & Sullivan
  • -
  • 122 pages

Summary

Table of Contents


Methodology

The majority of the quantitative and qualitative information contained in this research service was acquired through primary research conducted with mass spectrometry instrumentation providers and distributors. Most consultations were conducted with vice presidents (VPs) of business units, VPs of marketing, product managers, marketing managers, marketing directors, and business development directors from various competitors within the mass spectrometry market. Industry-specific information obtained include:
•Mass spectrometry revenue breakdowns by technology segments and regions
•Company revenues, market share estimates, and projected growth rates of various competitors
•Top-level customer, regional, and technology market trend information
•Market drivers, restraints, and challenges Supplementary research was conducted utilizing secondary sources including scientific journals, online media, Frost & Sullivan databases and research services, and publicly available corporate filings. Forecasts are based on the data and analyses regarding industry challenges, market drivers and restraints, and market trends. If specific revenues or market sizes were unavailable, estimates were derived through the consultations with industry experts, augmented by secondary research. Growth trends specific to certain market participants are based on consultations, past growth rates, and technology reviews.

Key Findings

•The global mass spectrometry market generated $xx million in 2012 at a base year growth rate of XX%. Growth is expected to pick up beyond 2013 as US and European economies improve, with a compound annual growth rate (CAGR) of XX% expected during the period from 2012 to 2017.
•This market is growing well above the high-end analytical instrumentation market, a sign this technologically-improving market of broad applications and diversified end-user bases is in high demand despite limited capital equipment budgets in academia and economic uncertainty in the US and Europe. Strong growth in the Asia-Pacific (APAC) and Rest of World (ROW) regions help offset lower growth in other regions.
•Regional segmentation determined that the US market generated $xx million in revenue in 2012 growing at a CAGR of XX% through 2017, Europe accounted for $XX million growing at a XX% CAGR, and APAC/ROW produced $XX in revenue growing at a XX% CAGR.
•Technology segmentation determined the single quadrupole LC/MS segment generated $XX million in 2012 growing at a CAGR of XX through 2017, tandem LC/MS accounted for $XX million growing at a XX% CAGR, time-of-flight (TOF) LC/MS drove $XX million with a CAGR of XX%, and MALDI-TOF MS produced $XX in revenue and will grow at a XX CAGR through 2017.
•Approximately 10 companies competed in the global mass spectrometry markets in 2012, including AB Sciex (Danaher Corporation), Agilent, Bruker Corporation, IONICS Mass Spectrometry, JEOL Ltd, LECO Corporation, PerkinElmer Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., and Waters Corporation leading the way. The market is highly concentrated with XX% of share controlled by the top 3 competitors, AB Sciex, Thermo Fisher, and Agilent.
•Key companies to watch in ancillary mass spectrometry technology markets include Australian Scientific Instruments Pty Ltd, Microsaic Systems plc, and Protea Biosciences Group, Inc. They are discussed later in this analysis.
•The collection of application, technology, and regional trends will combine to drive a XX% CAGR from 2012 to 2017. The key factors affecting the global mass spectrometry market forecast are summarized below:
-Application Drivers: Clinical diagnostics acceptance, applied testing in emerging economies, expanding use along the drug development pipeline, and new applications enabled by qualitative/quantitative (qual/quant) capabilities
-Technology Trends: Fast pace of technological advancement in triple quadrupole LC/MS and Q-TOF in particular, launch of clinically-focused instruments, and development of qual/quant platforms
-Macroeconomic Trends: US sequestration measures, European economic stagnation, double-digit growth in APAC, and ROW yet softening
-Regulatory Trends: Need for ISO 13485 certification for product development facilities in order to design instruments capable of gaining CE-IVD device registration in Europe and Class-1 medical device listing in the US for the clinical diagnostics market as well as increased regulations on food and beverage testing in emerging economics

Key Questions This Study Will Answer

How has the market responded to regional economic climates?
What application trends are driving adoption of the various mass spectrometry technologies globally?
Which competitors are competing successfully in their technology segments and why?
What ancillary or emerging companies should instrument providers be aware of?
What customer bases offer new opportunities for growth in the future?
How will acceptance of mass spectrometry for clinical applications spur the market?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

2017 Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

2017 Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.